Are you Dr. Pawarode?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- Dr. Attaphol Pawarode, MD is an oncologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan. He is affiliated with University of Michigan Medical Center and Veterans Affairs Ann Arbor Healthcare System.
Education & Training
- University at BuffaloFellowship, Hematology and Medical Oncology, 2005 - 2007
- University at BuffaloFellowship, Hematology and Medical Oncology, 2003 - 2005
- MedStar Health/Harbor HospitalResidency, Internal Medicine, 2001 - 2003
- Chulalongkorn University Faculty of MedicineClass of 1994
Certifications & Licensure
- MI State Medical License 2007 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen Start of enrollment: 2008 Feb 01
- Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 1 citationsOutcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy.Santiago Mercadal, Kwang Woo Ahn, Mariam Allbee-Johnson, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari
Haematologica. 2025-01-01 - Autologous non-myeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: identifying disease risk factors for toxicity and long-t...George E Georges, Dinesh Khanna, Mark H Wener, Matthew G Mei, Maureen D Mayes
Arthritis & Rheumatology. 2024-12-03 - 2 citationsDonor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
Professional Memberships
- Member